DocGo Inc. (DCGO) Form 8-K — May 11, 2026
DocGo Inc. reported a total revenue of $75.6 million for the first quarter of 2026, a 21.2% decline from $96.0 million in the first quarter of 2025. This decline was entirely due to the wind-down of migrant-related programs, which generated zero revenue in the first quarter of 2026 compared to $35.0 million in the first quarter of 2025. Excluding the migrant-related programs, DocGo's core business revenue increased by 19.3% to $75.6 million in the first quarter of 2026 from $61.0 million in the first quarter of 2025.
Key figures
- Eps
- -0.15
- Revenue
- 75.6 million
- Net Income
- -16.7 million
- Total Debt
- 98.016 million
- Revenue Yoy
- -21.2%
- Cash Position
- 59.9 million
- Adjusted EBITDA
- -10.2 million
- Patient Assignments
- 1.6 million
- Adjusted Gross Margin
- 31.6%
- Prior Patient Assignments
- 1.45 million
- Steady MDRevenue Growth2026
- 50%
- Migrant Program Revenue2025
- 35.0 million
- Migrant Program Revenue2026
- 0
- Mobile Phlebotomy Revenue Growth2026
- 131%
- Sequential Healthcare At Any Address Revenue
- 36%
Price after filing
Close on the filing date to close N calendar days later (from $0.59). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.